ReportGem ReportGem 中文

REAL-TIME GLOBAL RESEARCH

Healthcare Facilities & Managed Care MA Enrollment Tracker - June Data Shows Growth of 1.2% YTD; Individual Up 1.6% YTD; Duals Up 4.4% YTD

Published: 2026-06-18Institution: UBS EquitiesPages: 17Original language: EnglishEvidence page: 11

Research evidence excerpt

Healthcare Facilities & Managed Care MA Enrollment Tracker - June Data Shows Growth of 1.2% YTD; Individual Up 1.6% YTD; Duals Up 4.4% YTD

derations. UBS Pharma Values is an analytical tool that

involves the creation of a number of individual product net present value calculations, based on published forecasts of sales for pharmaceuticals, and is available

to clients of UBS Global Research; for further details and pricing please contact your UBS Sales representative. For all other specific disclaimers, please see https://

www.ubs.com/disclosures.

When you receive UBS Global Research through a system, your access and/or use of such UBS Global Research is subject to this UBS Global Research Disclaimer

and to the UBS Neo Platform Use Agreement (the "Neo Terms") together with any other relevant terms of use governing the applicable System.

When you receive UBS Global Research via a third party vendor, e-mail or other electronic means, you agree that use shall be subject to this UBS Global Research

Disclaimer, the Neo Terms and where applicable the UBS Investment Bank terms of business (https://www.ubs.com/global/en/investment-bank/regulatory.html)

and to UBS's Terms of Use/Disclaimer (https://www.ubs.com/global/en/legalinfo2/disclaimer.html). In addition, you consent to UBS processing your personal data

and using cookies in accordance with our Privacy Statement (https://www.ubs.com/global/en/legalinfo2/privacy.html) and cookie notice (https://www.ubs.com/

global/en/legal/privacy/users.html).

If you receive UBS Global Research, whether through a System or by any other means, you agree that you shall not copy, revise, amend, create a

derivative work, provide to any third party, or in any way commercially exploit any UBS research provided via UBS Global Research or otherwise,

The English excerpt is extracted automatically from the cited source page and may contain layout or recognition errors. It is never batch translated.

Open report viewer